The Estrogen-Receptor Antagonist Fulvestrant in Breast Cancer

In this segment, Edith Perez, MD; Carlos L. Arteaga, MD; and Denise A. Yardley, MD, and moderator Adam Brufsky, MD, PhD, discuss data for fulvestrant in first-and second-line settings.